TRANSGENOMIC INC
10-Q, EX-27, 2000-11-13
LABORATORY ANALYTICAL INSTRUMENTS
Previous: TRANSGENOMIC INC, 10-Q, EX-10.2, 2000-11-13
Next: GEORGIA CAROLINA BANCSHARES INC, 10QSB, 2000-11-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      60,431,360
<SECURITIES>                                         0
<RECEIVABLES>                                5,691,365
<ALLOWANCES>                                   225,181
<INVENTORY>                                  2,729,610
<CURRENT-ASSETS>                            76,782,647
<PP&E>                                       5,873,997
<DEPRECIATION>                               2,276,388
<TOTAL-ASSETS>                              83,460,527
<CURRENT-LIABILITIES>                        6,867,128
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       214,029
<OTHER-SE>                                  76,379,370
<TOTAL-LIABILITY-AND-EQUITY>                83,460,128
<SALES>                                     18,785,721
<TOTAL-REVENUES>                            19,705,698
<CGS>                                        9,401,352
<TOTAL-COSTS>                               16,803,889
<OTHER-EXPENSES>                                13,160
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,776,110
<INCOME-PRETAX>                            (3,288,813)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (8,288,813)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (8,288,813)
<EPS-BASIC>                                      (.55)
<EPS-DILUTED>                                    (.55)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission